Target intelligence / Profile preview

Bactericidal properties

Molecular classification
Other
01

Overview

Bactericidal properties refers to the capacity of a chemical, biological, or physical agent to induce the death of bacterial cells rather than merely inhibiting their growth. This characteristic is a fundamental pharmacodynamic property of many antibiotics, disinfectants, and certain endogenous immune proteins, such as the Bactericidal/permeability-increasing protein (BPI). In clinical medicine, bactericidal agents are particularly critical for treating infections in 'privileged' sites like the central nervous system (meningitis) or the heart (endocarditis), where host immune clearance is insufficient. The bactericidal effect is typically achieved by targeting essential bacterial structures or processes, such as cell wall synthesis, cytoplasmic membrane integrity, or DNA replication, leading to irreversible damage and cell lysis. While highly effective, the use of bactericidal agents must be balanced against risks like the Jarisch-Herxheimer reaction and the selective pressure for antibiotic resistance. Because 'Bactericidal properties' represents a functional outcome or phenotype rather than a discrete molecular entity like a receptor or enzyme, it is classified as a descriptive property of an agent's mechanism of action.

Other names
Bactericidal activityBactericidal effectAntibacterial activityBactericidal action
02

Mechanism of action

Bactericidal agents work by causing irreversible damage to the bacteria, often through the inhibition of cell wall synthesis (leading to osmotic lysis), disruption of the cell membrane (leading to leakage of intracellular contents), or interference with essential enzymes such as DNA gyrase or RNA polymerase, which prevents DNA repair and synthesis.

03

Biological functions

Bacterial cell deathInhibition of bacterial replicationLysis of bacterial cell wallDisruption of bacterial membrane integrityInduction of lethal DNA damage
04

Disease associations

Bacterial infectionSepsisBacteremiaMeningitisEndocarditis
05

Safety considerations

Antibiotic resistance developmentDisruption of commensal microbiota (Dysbiosis)Jarisch-Herxheimer reaction (due to rapid release of bacterial endotoxins)Potential for systemic toxicity at high bactericidal concentrations
06

Interacting drugs

Penicillin

7 more in the full profile.

07

Biomarkers

Minimum Bactericidal Concentration (MBC)Bactericidal indexTime-kill kinetics/curvesFractional Inhibitory Concentration Index (FICI)

Beyond the preview

Go deeper on Bactericidal properties.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bactericidal properties.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call